DOCS Classe A Doximity, Inc. Class A Common Stock
NYSE · Health Care · Voir sur SEC EDGAR ↗ clôture Oct 2, 2026 10-K/10-Q Aoû 6, 2026DOCS Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
DOCS Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.
À propos de Doximity, Inc. Class A Common Stock Présentation de l'entreprise depuis Wikipedia
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
History
The company was launched in March 2011 by co-founders Nate Gross, Jeff Tangney and Shari Buck. In 2013, founder Jeff Tangney remained CEO while the company was based in San Mateo, California. By 2013, it became one of the largest networks for U.S. healthcare professionals, with approximately 10 percent of U.S. doctors as members.
By the beginning of 2014, 40 percent of U.S. physicians became members. In 2016, it began offering a free service for doctors to call patients using their work number on their mobile phones. In 2018, the company announced that it had reached 1 million members, accounting for more than 70 percent of U.S. physicians. In 2021, Doximity served more than 2 million registered members, including over 80 percent of U.S. physicians and over 50 percent of nurse practitioners and physician assistants.
In 2016, the company was ranked #6 on the Deloitte Technology Fast 500 list. In November 2019, Doximity was listed on the Deloitte Technology Fast 500 list for the fourth consecutive year. In May 2020, the company added video. Dialer Video, a video telehealth app, allows physicians to video call patients through personal smartphones. In June 2020, Doximity Acquires THMED and launches the Curative Brand. Curative is a staffing and recruiting company offering permanent and Locum/Temporary placement services.
In May 2021, Doximity, a professional network for physicians with telehealth and scheduling tools, filed for an initial public offering (IPO) seeking to raise $100 million. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities were the lead underwriters for the IPO. Doximity raised nearly $606 million in its IPO. In its June 2021 IPO on the NYSE, gave it a market cap shortly after its debut of $9.4 billion.
In 2021 August, CNBC reported that the site's news feed was "inundated" with vaccine misinformation shared among physicians, despite Doximity's community guidelines banning medical misinformation. At the time, 80% of its revenue came from ads paid by pharmaceutical firms and hospitals, and directed at physicians on the site. In November 2023, Doximity released DocDefender, a free service that removed a physician's personal phone numbers and addresses from public websites.
Investors
In April 2014, the company announced it had raised a $54 million financing round led by the venture capital firm Draper Fisher Jurvetson and the mutual fund company T. Rowe Price. Morgan Stanley Investment Management also invested. This investment brought Doximity's total funding to $81 million. Doximity received $10.8 million in venture capital funding from Emergence Capital Partners and Interwest Partners in March 2011, and $17 million in Series B funding led by Morgenthaler Ventures in September 2012.
Products and services
Dialer
In 2016, Doximity built Dialer, a free communication tool for physicians to call their patients. The Doximity Dialer app allows physicians to call patients from their personal cell phone, and the patient sees the doctor's office number on caller ID.
Dialer Video
In May 2020, Doximity released Dialer Video, a telemedicine tool that allows physicians to video call their patients directly from their own smartphones. In July 2020, Doximity said that more than 100,000 U.S. Doctors use Dialer Video, its telemedicine app.
Acquisition
In June 2020, Doximity acquired THMED, a healthcare company. Following the purchase, THMED changed its name to Curative and started concentrating on customized medical-personnel queries. In February 2022, Doximity acquired Amion, an on-call doctor scheduling company. In August 2025, Doximity acquired Pathway Medical, a Canadian startup specializing in medical AI and evidence-based clinical reference tools.
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
| Métrique | Tendance sur 5 ans | DOCS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 33.2moyenne 5 ans ≈49.8 | ≈49.8 | · | · | |
| P/S (TTM) | 7.7moyenne 5 ans ≈16.1 | ≈16.1 | · | · | |
| P/B (MRQ) | 5.5moyenne 5 ans ≈7.6 | ≈7.6 | · | · | |
| Price / FCF (Cours / FCF) | 15.7moyenne 5 ans ≈39.2 | ≈39.2 | · | · | |
| Price / Cash Flow (Cours / Flux de trésorerie) | 15.7moyenne 5 ans ≈38.9 | ≈38.9 | · | · | |
| Cours / Actif net tangible (MRQ) | 5.7moyenne 5 ans ≈8.3 | ≈8.3 | · | · | |
| PEG Ratio (Ratio PEG) | ≈1.0 | · | · | · |
La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
| Métrique | Tendance sur 5 ans | DOCS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Marge Brute (TTM) | 88.1%moyenne 5 ans ≈88.9% | ≈88.9% | · | · | |
| Marge d'exploitation (TTM) | 29.6%moyenne 5 ans ≈34.1% | ≈34.1% | · | · | |
| Marge EBITDA (TTM) | 32.0%moyenne 5 ans ≈36.2% | ≈36.2% | · | · | |
| Marge avant impôts (TTM) | 34.5%moyenne 5 ans ≈37.8% | ≈37.8% | · | · | |
| Marge nette (TTM) | 25.5%moyenne 5 ans ≈34.5% | ≈34.5% | · | · | |
| ROA (TTM) | 14.6%moyenne 5 ans ≈16.9% | ≈16.9% | · | · | |
| ROE (TTM) | 17.2%moyenne 5 ans ≈17.4% | ≈17.4% | · | · | |
| ROIC | 17.7%moyenne 5 ans ≈15.7% | ≈15.7% | · | · |
Santé financière Dette, liquidité, solvabilité — solidité du bilan
| Métrique | Tendance sur 5 ans | DOCS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Ratio de liquidité (MRQ) | 6.1moyenne 5 ans ≈6.9 | ≈6.9 | · | · | |
| Quick Ratio (Ratio de liquidité réduite) | 2.3moyenne 5 ans ≈1.9 | ≈1.9 | · | · |
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
| Métrique | Tendance sur 5 ans | DOCS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue YoY (Chiffre d'affaires YoY) | 13.1%moyenne 5 ans ≈26.9% | ≈26.9% | · | · | |
| Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans) | 15.4%moyenne 5 ans ≈21.9% | ≈21.9% | · | · | |
| Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans) | 25.5% | · | · | · | |
| EPS YoY (BPA Année/Année) | -11.7%moyenne 5 ans ≈51.7% | ≈51.7% | · | · | |
| Net Income YoY (Bénéfice net YoY) | -12.2%moyenne 5 ans ≈50.2% | ≈50.2% | · | · | |
| EPS CAGR 3Y (TCAC BPA 3 ans) | 22.7%moyenne 5 ans ≈28.5% | ≈28.5% | · | · | |
| EPS CAGR 5Y (TCAC BPA 5 ans) | 33.6% | · | · | · | |
| Net Income CAGR 3Y (TCAC Bénéfice net 3 ans) | 20.2%moyenne 5 ans ≈25.5% | ≈25.5% | · | · | |
| Net Income CAGR 5Y (TCAC Bénéfice net 5 ans) | 31.3% | · | · | · |
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
| Métrique | Tendance sur 5 ans | DOCS | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Asset Turnover (Rotation des actifs) | 0.5moyenne 5 ans ≈0.5 | ≈0.5 | · | · | |
| Receivables Turnover (Rotation des créances) | 4.7moyenne 5 ans ≈4.8 | ≈4.8 | · | · | |
| Revenue / Employee (Chiffre d'affaires annuel ÷ employés (effectif déclaré, yfinance). Dérivé — pas un concept SEC-XBRL stocké.) | ≈$732.8K | · | · | · |
valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
| Période | Rapport | EPS Actual | BPA est. | Surprise |
|---|---|---|---|---|
| 30 juin 2026 | $0.29 | $0.31 | -6.7% | |
| 31 mars 2026 | $0.26 | $0.29 | -10.0% | |
| 31 décembre 2025 | $0.46 | $0.45 | 1.2% | |
| 30 septembre 2025 | $0.45 | $0.39 | 16.4% | |
| 30 juin 2025 | $0.36 | $0.31 | 17.5% | |
| 31 mars 2025 | $0.46 | $0.45 | 1.2% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $645M | $570M | $475M | $419M | $344M | $207M | $116M | |
| Cost of Revenue | $70M | $56M | $51M | $53M | $40M | $31M | $15M | |
| Gross Profit | $575M | $515M | $425M | $366M | $304M | $176M | $101M | |
| R&D Expense | $131M | $93M | $82M | $80M | $62M | $44M | $32M | |
| SG&A Expense | $65M | $46M | $38M | $37M | $36M | $16M | $7M | |
| Operating Expenses | $360M | $287M | $261M | $240M | $190M | $122M | $79M | |
| Operating Income | $215M | $228M | $164M | $125M | $114M | $53M | $22M | |
| Other Non-op | $-806.0K | $-247.0K | $62.0K | $-146.0K | $-448.0K | $4M | $1M | |
| Pretax Income | $250M | $264M | $185M | $133M | $114M | $58M | $24M | |
| Income Tax | $54M | $40M | $38M | $20M | $-41M | $8M | $-6M | |
| Net Income | $196M | $223M | $148M | $113M | $155M | $50M | $30M | |
| EPS (Basic) | $1.05 | $1.19 | $0.78 | $0.58 | $0.82 | $0.29 | $0.16 | |
| EPS (Diluted) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | $0.23 | $0.13 | |
| Shares (Basic) | 187,014,000 | 186,841,000 | 190,172,000 | 193,176,000 | 163,484,000 | 74,342,000 | 66,758,000 | |
| Shares (Diluted) | 199,048,000 | 201,208,000 | 205,734,000 | 213,425,000 | 191,017,000 | 95,134,000 | 81,710,000 | |
| EBITDA | $229M | $238M | $174M | $135M | $119M | · | · |
Bilan
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $219M | $210M | $97M | $158M | $113M | $66M | · | |
| Receivables | $145M | $128M | $101M | $107M | $81M | $50M | · | |
| Prepaid Expense | $51M | $45M | $49M | $27M | $19M | $11M | · | |
| Current Assets | $944M | $1.09B | $913M | $975M | $904M | $209M | · | |
| PP&E (Net) | $18M | $14M | $12M | $11M | $8M | $8M | · | |
| PP&E (Gross) | $49M | $39M | $31M | $25M | $17M | $12M | · | |
| Accum. Depreciation | $31M | $25M | $19M | $14M | $8M | $5M | · | |
| Goodwill | $85M | $68M | $68M | $68M | $19M | $19M | · | |
| Intangibles | $35M | $23M | $27M | $32M | $8M | $10M | · | |
| Other Non-current Assets | $2M | $2M | $1M | $2M | $2M | $3M | · | |
| Total Assets | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Accounts Payable | $4M | $1M | $2M | $1M | $463.0K | $2M | · | |
| Accrued Liabilities | $43M | $38M | $44M | $31M | $25M | $16M | · | |
| Current Liabilities | $155M | $156M | $147M | $140M | $111M | $102M | · | |
| Capital Leases | $8M | $10M | $12M | $14M | $447.0K | $284.0K | · | |
| Other Non-current Liabilities | $9M | $9M | $7M | $1M | $956.0K | $972.0K | · | |
| Total Liabilities | $173M | $182M | $178M | $171M | $113M | $104M | · | |
| Common Stock | $183.0K | $189.0K | $187.0K | $194.0K | $192.0K | $83.0K | · | |
| Paid-in Capital | $1.00B | $894M | $824M | $762M | $703M | $30M | · | |
| Retained Earnings | $-51M | $187M | $80M | $218M | $191M | $36M | · | |
| AOCI | $28.0K | $1M | $-3M | $-14M | $-15M | $-21.0K | · | |
| Stockholders' Equity | $951M | $1.08B | $901M | $966M | $879M | $67M | $1M | |
| Liabilities + Equity | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Shares Outstanding | 183,060,000 | 188,875,000 | 186,562,000 | 193,941,000 | 192,398,000 | 82,910,000 | · |
Flux de trésorerie
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| D&A | $14M | $11M | $10M | $10M | $5M | $4M | $900.0K | |
| Stock-based Comp | $122M | $72M | $51M | $48M | $31M | $7M | $2M | |
| Deferred Tax | $32M | $-12M | $-9M | $13M | $-41M | $5M | $-7M | |
| Amort. of Intangibles | $6M | $4M | $5M | $5M | $1M | $1M | $0 | |
| Restructuring | · | $2M | $8M | $0 | $0 | · | · | |
| Other Non-cash | $-38M | $-21M | $-16M | $-5M | $-23M | · | · | |
| Operating Cash Flow | $326M | $273M | $184M | $180M | $127M | $83M | $26M | |
| CapEx | $0 | $0 | $147.0K | $2M | $2M | $245.0K | $285.0K | |
| Investing Cash Flow | $147M | $-29M | $31M | $-60M | $-641M | $-70M | $-13M | |
| Stock Repurchased | $432M | $120M | $281M | $85M | $3M | $2M | $0 | |
| Net Stock Activity | $-432M | $-120M | $-281M | $-85M | $-3M | · | · | |
| Financing Cash Flow | $-464M | $-131M | $-277M | $-74M | $560M | $5M | $2M | |
| Net Change in Cash | $10M | $113M | $-61M | $45M | $46M | $18M | $15M | |
| Taxes Paid | $22M | · | · | · | · | · | · | |
| Free Cash Flow | $326M | $273M | $184M | $178M | $125M | · | · |
Rentabilité
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% | · | · | |
| Operating Margin | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% | · | · | |
| Net Margin | 30.4% | 39.1% | 31.0% | 26.9% | 45.1% | · | · | |
| Pretax Margin | 38.8% | 46.2% | 39.0% | 31.8% | 33.2% | · | · | |
| EBITDA Margin | 35.6% | 41.8% | 36.6% | 32.3% | 34.5% | · | · | |
| ROA | 16.4% | 19.1% | 13.3% | 10.6% | 24.9% | · | · | |
| ROE | 19.2% | 21.1% | 16.7% | 11.9% | 18.0% | · | · | |
| ROIC | 17.7% | 17.8% | 14.5% | 11.0% | 17.5% | · | · |
Liquidité et Solvabilité
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 | · | · | |
| Quick Ratio | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 | · | · |
Efficacité
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.4 | 0.4 | 0.6 | · | · | |
| Receivables Turnover | 4.7 | 5.0 | 4.6 | 4.5 | 5.2 | · | · |
Par action
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.19 | $5.73 | $4.83 | $4.98 | $4.57 | · | · | |
| Revenue / Share | $3.24 | $2.83 | $2.31 | $1.96 | $1.80 | · | · | |
| Cash Flow / Share | $1.64 | $1.36 | $0.89 | $0.84 | $0.66 | · | · | |
| Cash / Share | $1.20 | $1.11 | $0.52 | $0.81 | $0.59 | · | · | |
| EPS (TTM) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | · | · |
Taux de croissance
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.1% | 20.0% | 13.5% | 22.0% | 66.0% | · | · | |
| Revenue CAGR 3Y | 15.4% | 18.4% | 32.0% | · | · | · | · | |
| Revenue CAGR 5Y | 25.5% | · | · | · | · | · | · | |
| EPS YoY | -11.7% | 54.2% | 35.9% | -24.3% | 204.3% | · | · | |
| EPS CAGR 3Y | 22.7% | 16.6% | 46.3% | · | · | · | · | |
| EPS CAGR 5Y | 33.6% | · | · | · | · | · | · | |
| Net Income YoY | -12.2% | 51.2% | 30.8% | -27.1% | 208.3% | · | · | |
| Net Income CAGR 3Y | 20.2% | 13.0% | 43.2% | · | · | · | · | |
| Net Income CAGR 5Y | 31.3% | · | · | · | · | · | · |
Valorisation (TTM)
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $645M | $570M | $475M | $419M | $344M | · | · | |
| Net Income TTM | $196M | $223M | $148M | $113M | $155M | · | · | |
| Market Cap | $4.27B | $10.96B | $5.02B | $6.28B | $10.02B | · | · | |
| P/E | 23.8 | 52.3 | 37.4 | 61.1 | 74.4 | · | · | |
| P/S | 6.6 | 19.2 | 10.6 | 15.0 | 29.2 | · | · | |
| P/B | 4.5 | 10.1 | 5.6 | 6.5 | 11.4 | · | · | |
| P / Tangible Book | 5.1 | 11.1 | 6.2 | 7.2 | 11.8 | · | · | |
| P / Cash Flow | 13.1 | 40.1 | 27.3 | 35.0 | 79.2 | · | · | |
| P / FCF | 13.1 | 40.1 | 27.3 | 35.3 | 80.4 | · | · | |
| Earnings Yield | 4.2% | 1.9% | 2.7% | 1.6% | 1.3% | · | · |
Compte de résultat
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $157M | $145M | $185M | $169M | $146M | $138M | $169M | $137M | $127M | $118M | $135M | $114M | $108M | $111M | $115M | $102M | |
| Cost of Revenue | $24M | $19M | $19M | $16M | $16M | $14M | $14M | $14M | $14M | $13M | $12M | $13M | $13M | $14M | $14M | $13M | |
| Gross Profit | $133M | $126M | $166M | $152M | $130M | $124M | $154M | $123M | $113M | $105M | $123M | $101M | $95M | $97M | $102M | $89M | |
| R&D Expense | $38M | $39M | $35M | $30M | $27M | $25M | $22M | $23M | $23M | $20M | $20M | $20M | $22M | $22M | $21M | $19M | |
| SG&A Expense | $16M | $16M | $18M | $19M | $12M | $13M | $14M | $10M | $9M | $10M | $10M | $9M | $9M | $10M | $10M | $9M | |
| Operating Expenses | $99M | $101M | $94M | $88M | $76M | $75M | $74M | $70M | $67M | $64M | $65M | $67M | $66M | $64M | $63M | $57M | |
| Operating Income | $34M | $25M | $72M | $64M | $55M | $49M | $80M | $53M | $46M | $42M | $59M | $34M | $30M | $33M | $38M | $32M | |
| Other Non-op | $-286.0K | $-235.0K | $-158.0K | $-178.0K | $-235.0K | $-51.0K | $-30.0K | $-114.0K | $-52.0K | $73.0K | $-55.0K | $-50.0K | $94.0K | $-27.0K | $-25.0K | $-48.0K | |
| Pretax Income | $40M | $32M | $81M | $73M | $64M | $58M | $90M | $62M | $53M | $48M | $63M | $40M | $35M | $37M | $41M | $33M | |
| Income Tax | $16M | $13M | $19M | $11M | $11M | $-4M | $15M | $18M | $12M | $7M | $15M | $9M | $6M | $6M | $7M | $7M | |
| Net Income | $24M | $19M | $62M | $62M | $53M | $62M | $75M | $44M | $41M | $41M | $48M | $31M | $28M | $31M | $33M | $26M | |
| EPS (Basic) | $0.13 | $0.11 | $0.33 | $0.33 | $0.28 | $0.33 | $0.40 | $0.24 | $0.22 | $0.21 | $0.26 | $0.16 | $0.15 | $0.15 | $0.17 | $0.14 | |
| EPS (Diluted) | $0.13 | $0.09 | $0.31 | $0.31 | $0.27 | $0.31 | $0.37 | $0.22 | $0.21 | $0.20 | $0.24 | $0.15 | $0.13 | $0.15 | $0.16 | $0.12 | |
| Shares (Basic) | 182,569,000 | · | 187,478,000 | 187,705,000 | 187,984,000 | · | 187,161,000 | 186,252,000 | 185,610,000 | · | 186,309,000 | 193,112,000 | 194,521,000 | · | 192,805,000 | 193,137,000 | |
| Shares (Diluted) | 191,169,000 | · | 199,224,000 | 200,745,000 | 201,158,000 | · | 202,233,000 | 200,407,000 | 199,224,000 | · | 200,463,000 | 209,014,000 | 212,355,000 | · | 212,065,000 | 213,949,000 | |
| EBITDA | $38M | · | $72M | $64M | $57M | · | $80M | $53M | $49M | · | $59M | $34M | $32M | · | $38M | $32M |
Bilan
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $274M | $219M | $65M | $169M | $137M | $210M | $165M | $184M | $111M | $97M | $123M | $108M | $307M | · | $136M | $74M | |
| Receivables | $178M | $145M | $157M | $129M | $142M | $128M | $138M | $125M | $121M | $101M | $98M | $97M | $93M | · | $75M | $79M | |
| Prepaid Expense | $49M | $51M | $102M | $85M | $52M | $45M | $30M | $27M | $37M | $49M | $27M | $33M | $20M | · | $17M | $16M | |
| Current Assets | $914M | $944M | $993M | $1.09B | $1.03B | $1.09B | $1.01B | $958M | $908M | $913M | $841M | $863M | $990M | · | $899M | $848M | |
| PP&E (Net) | $19M | $18M | $17M | $16M | $14M | $14M | $13M | $13M | $13M | $12M | $12M | $12M | $12M | · | $12M | $12M | |
| PP&E (Gross) | $53M | $49M | $47M | $43M | $41M | $39M | $37M | $35M | $33M | $31M | $29M | $28M | $26M | · | $24M | $22M | |
| Accum. Depreciation | $34M | $31M | $30M | $28M | $26M | $25M | $23M | $22M | $21M | $19M | $18M | $16M | $15M | · | $12M | $11M | |
| Goodwill | $85M | $85M | $85M | $85M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | · | $68M | $68M | |
| Intangibles | $33M | $35M | $37M | $39M | $22M | $23M | $24M | $25M | $26M | $27M | $28M | $29M | $31M | · | $33M | $34M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | · | $1M | $1M | |
| Total Assets | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Accounts Payable | $6M | $4M | $5M | $4M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $714.0K | $582.0K | · | $2M | $1M | |
| Accrued Liabilities | $33M | · | $77M | $34M | $38M | $38M | $43M | $34M | $28M | $44M | $34M | $29M | $32M | · | $33M | $26M | |
| Current Liabilities | $150M | $155M | $150M | $140M | $160M | $156M | $116M | $132M | $135M | $147M | $105M | $123M | $133M | · | $106M | $118M | |
| Capital Leases | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | $13M | $14M | · | $14M | $15M | |
| Other Non-current Liabilities | $10M | $9M | $19M | $12M | $9M | $9M | $9M | $8M | $7M | $7M | $841.0K | $7M | $6M | · | $1M | $1M | |
| Total Liabilities | $168M | $173M | $178M | $162M | $179M | $182M | $141M | $157M | $160M | $178M | $136M | $154M | $163M | · | $137M | $149M | |
| Common Stock | $180.0K | $183.0K | $185.0K | $188.0K | $187.0K | $189.0K | $188.0K | $187.0K | $186.0K | $187.0K | $186.0K | $188.0K | $195.0K | · | $193.0K | $192.0K | |
| Paid-in Capital | $1.04B | $1.00B | $957M | $936M | $907M | $894M | $879M | $863M | $841M | $824M | $808M | $795M | $778M | · | $746M | $731M | |
| Retained Earnings | $-119M | $-51M | $21M | $158M | $117M | $187M | $151M | $95M | $73M | $80M | $61M | $85M | $225M | · | $203M | $170M | |
| AOCI | $-348.0K | $28.0K | $1M | $1M | $1M | $1M | $1M | $3M | $-1M | $-3M | $-5M | $-9M | $-12M | · | $-19M | $-22M | |
| Stockholders' Equity | $916M | $951M | $979M | $1.10B | $1.03B | $1.08B | $1.03B | $961M | $914M | $901M | $865M | $871M | $991M | $966M | $930M | $879M | |
| Liabilities + Equity | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Shares Outstanding | 179,849,000 | 183,060,000 | 184,992,000 | 188,090,000 | 187,453,000 | 188,875,000 | 187,584,000 | 186,781,000 | 185,704,000 | 186,562,000 | 186,175,000 | 188,518,000 | 194,649,000 | 193,941,000 | 193,252,000 | 192,302,000 |
Flux de trésorerie
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $37M | $37M | $34M | $29M | $22M | $18M | $19M | $18M | $17M | $12M | $12M | $13M | $14M | $13M | $14M | $11M | |
| Deferred Tax | · | $32M | $0 | · | · | $-14M | $2M | · | · | $-9M | $0 | $0 | $0 | $4M | $9M | $0 | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | · | · | · | · | · | $0 | $0 | $2M | · | $0 | $0 | $8M | · | $0 | $0 | $0 | |
| Other Non-cash | $-23M | · | · | · | $-16M | · | · | · | $-20M | · | · | · | $12M | · | · | · | |
| Operating Cash Flow | $42M | $110M | $61M | $94M | $62M | $98M | $65M | $68M | $41M | $64M | $50M | $13M | $57M | $47M | $49M | $40M | |
| CapEx | $62.0K | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $36.0K | $41.0K | $70.0K | $21.0K | $204.0K | $766.0K | |
| Investing Cash Flow | $113M | $138M | $38M | $-32M | $3M | $-24M | $-59M | $24M | $30M | $-76M | $40M | $-50M | $117M | $-13M | $13M | $-19M | |
| Stock Repurchased | $92M | $91M | $197M | $22M | $122M | $27M | $19M | $23M | $51M | $18M | $77M | $164M | $22M | $15M | $0 | $61M | |
| Net Stock Activity | $-92M | · | · | · | $-122M | · | · | · | $-51M | · | · | · | $-22M | · | · | · | |
| Financing Cash Flow | $-101M | $-93M | $-204M | $-30M | $-137M | $-30M | $-25M | $-20M | $-57M | $-14M | $-76M | $-161M | $-26M | $-12M | $779.0K | $-57M | |
| Net Change in Cash | $54M | $154M | $-104M | $32M | $-72M | $44M | $-19M | $73M | $15M | $-26M | $15M | $-198M | $149M | $22M | $63M | $-36M | |
| Taxes Paid | · | · | · | · | · | · | $14M | $9M | $13M | · | $9M | $29M | $0 | · | $2M | · | |
| Free Cash Flow | $42M | · | · | · | · | · | · | · | $41M | · | · | · | $57M | · | · | · |
Rentabilité
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 84.9% | · | 89.9% | 90.2% | 89.2% | · | 91.6% | 90.0% | 89.3% | · | 91.0% | 88.8% | 87.9% | · | 88.3% | 87.1% | |
| Operating Margin | 21.5% | · | 38.9% | 37.8% | 37.4% | · | 47.4% | 38.8% | 36.4% | · | 43.3% | 29.7% | 27.4% | · | 33.4% | 31.4% | |
| Net Margin | 15.5% | · | 33.3% | 36.8% | 36.5% | · | 44.6% | 32.3% | 32.7% | · | 35.4% | 26.9% | 26.2% | · | 29.0% | 25.7% | |
| Pretax Margin | 25.8% | · | 43.7% | 43.3% | 44.0% | · | 53.3% | 45.4% | 42.0% | · | 46.6% | 34.9% | 31.8% | · | 35.5% | 32.3% | |
| EBITDA Margin | 24.2% | · | 38.9% | 37.8% | 39.3% | · | 47.4% | 38.8% | 38.4% | · | 43.3% | 29.7% | 29.8% | · | 33.4% | 31.4% | |
| ROA | 2.1% | · | 5.3% | 5.2% | 4.7% | · | 6.9% | 4.1% | 3.7% | · | 4.6% | 3.0% | 2.6% | · | 3.4% | 2.8% | |
| ROE | 2.5% | · | 6.1% | 6.0% | 5.5% | · | 7.9% | 4.8% | 4.3% | · | 5.3% | 3.5% | 3.0% | · | 3.8% | 3.2% | |
| ROIC | 2.2% | · | 5.6% | 5.0% | 4.4% | · | 6.5% | 3.9% | 3.9% | · | 5.1% | 3.0% | 2.5% | · | 3.4% | 2.9% |
Liquidité et Solvabilité
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | · | 6.6 | 7.8 | 6.5 | · | 8.7 | 7.2 | 6.7 | · | 8.0 | 7.0 | 7.5 | · | 8.5 | 7.2 | |
| Quick Ratio | 3.0 | · | 1.5 | 2.1 | 1.7 | · | 2.6 | 2.3 | 1.7 | · | 2.1 | 1.7 | 3.0 | · | 2.0 | 1.3 |
Efficacité
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Receivables Turnover | 1.0 | · | 1.3 | 1.3 | 1.1 | · | 1.4 | 1.2 | 1.2 | · | 1.6 | 1.3 | 1.3 | · | 1.6 | 1.5 |
Par action
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.09 | · | $5.29 | $5.82 | $5.47 | · | $5.50 | $5.15 | $4.92 | · | $4.64 | $4.62 | $5.09 | · | $4.81 | $4.57 | |
| Revenue / Share | $0.82 | · | $0.93 | $0.84 | $0.73 | · | $0.83 | $0.68 | $0.64 | · | $0.67 | $0.54 | $0.51 | · | $0.54 | $0.48 | |
| Cash Flow / Share | $0.22 | · | · | · | $0.31 | · | · | · | $0.21 | · | · | · | $0.27 | · | · | · | |
| Cash / Share | $1.52 | · | $0.35 | $0.90 | $0.73 | · | $0.88 | $0.99 | $0.60 | · | $0.66 | $0.57 | $1.58 | · | $0.71 | $0.38 | |
| EPS (TTM) | $0.84 | · | $1.20 | $1.26 | $1.17 | · | $1.00 | $0.87 | $0.80 | · | $0.67 | $0.59 | $0.56 | · | $0.56 | $0.66 |
Valorisation (TTM)
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $656M | · | $638M | $621M | $590M | · | $550M | $517M | $494M | · | $468M | $448M | $437M | · | $402M | $384M | |
| Net Income TTM | $167M | · | $239M | $253M | $235M | · | $201M | $174M | $161M | · | $138M | $123M | $119M | · | $119M | $141M | |
| Market Cap | $3.73B | · | $8.19B | $13.76B | $11.50B | · | $10.02B | $8.14B | $5.19B | · | $5.22B | $4.00B | $6.62B | · | $6.49B | $5.81B | |
| P/E | 24.7 | · | 36.9 | 58.1 | 52.4 | · | 53.4 | 50.1 | 35.0 | · | 41.9 | 36.0 | 60.8 | · | 59.9 | 45.8 | |
| P/S | 5.7 | · | 12.8 | 22.1 | 19.5 | · | 18.2 | 15.7 | 10.5 | · | 11.1 | 8.9 | 15.2 | · | 16.1 | 15.1 | |
| P/B | 4.1 | · | 8.4 | 12.6 | 11.2 | · | 9.7 | 8.5 | 5.7 | · | 6.0 | 4.6 | 6.7 | · | 7.0 | 6.6 | |
| P / Tangible Book | 4.7 | · | 9.6 | 14.2 | 12.3 | · | 10.7 | 9.4 | 6.3 | · | 6.8 | 5.2 | 7.4 | · | 7.8 | 7.5 | |
| P / Cash Flow | 88.8 | · | · | · | 185.2 | · | · | · | 125.9 | · | · | · | 115.8 | · | · | · | |
| Earnings Yield | 4.0% | · | 2.7% | 1.7% | 1.9% | · | 1.9% | 2.0% | 2.9% | · | 2.4% | 2.8% | 1.7% | · | 1.7% | 2.2% |
Période la plus récente à gauche · valeurs nulles affichées comme ·
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
| Métrique | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Revenu | $645M | $570M | $475M | $419M | $344M |
| Marge Brute % | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% |
| Marge d'exploitation % | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% |
| Résultat net | $196M | $223M | $148M | $113M | $155M |
| BPA dilué | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 |
| Métrique | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Ratio de liquidité | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 |
| Ratio de liquidité réduite | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 |
| Métrique | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $326M | $273M | $184M | $178M | $125M |
Détenteurs institutionnels (13F) 410 déclarants · $3.3B total · Au 30 septembre 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 44 (-51 vs T. préc.) | 100 (-12 vs T. préc.) | 132 (-36 vs T. préc.) | 147 (+21 vs T. préc.) | +3.0M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $588 281 276 | 13 285 485 | 17,59% | Actions |
| BlackRock, Inc. | $296 729 585 | 14 307 116 | 8,87% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $132 468 433 | 6 387 099 | 3,96% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $123 971 960 | 5 977 433 | 3,71% | Actions |
| D. E. Shaw & Co., Inc. | $122 826 179 | 5 922 188 | 3,67% | Actions |
| TWO SIGMA INVESTMENTS, LP | $96 385 189 | 4 647 309 | 2,88% | Actions |
| STATE STREET CORP | $87 334 253 | 4 210 909 | 2,61% | Actions |
| GOLDMAN SACHS GROUP INC | $84 762 882 | 4 086 928 | 2,53% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $79 848 140 | 3 849 310 | 2,39% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $65 022 244 | 3 135 113 | 1,94% | Actions |
| DEUTSCHE BANK AG\ | $60 011 895 | 2 893 534 | 1,79% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $59 184 680 | 2 853 649 | 1,77% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $55 840 936 | 2 692 427 | 1,67% | Actions |
| Carmignac Gestion | $48 861 366 | 2 355 900 | 1,46% | Actions |
| FEDERATED HERMES, INC. | $48 345 085 | 2 331 007 | 1,45% | Actions |
| MORGAN STANLEY | $46 575 609 | 2 245 689 | 1,39% | Actions |
| LOOMIS SAYLES & CO L P | $45 345 771 | 2 186 392 | 1,36% | Actions |
| Squarepoint Ops LLC | $45 090 336 | 2 174 076 | 1,35% | Actions |
| MILLENNIUM MANAGEMENT LLC | $42 902 785 | 2 068 601 | 1,28% | Actions |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $42 682 967 | 1 831 887 | 1,28% | Actions |
| Invesco Ltd. | $39 908 904 | 1 924 248 | 1,19% | Actions |
| Amundi | $39 467 726 | 1 902 977 | 1,18% | Actions |
| NORGES BANK | $39 178 461 | 1 889 029 | 1,17% | Actions |
| AQR CAPITAL MANAGEMENT LLC | $37 860 213 | 1 838 767 | 1,13% | Actions |
| Gotham Asset Management, LLC | $35 523 762 | 1 712 814 | 1,06% | Actions |
| CITADEL ADVISORS LLC | $32 385 137 | 1 561 482 | 0,97% | Actions |
| Iron Triangle Partners LP | $30 401 231 | 686 568 | 0,91% | Actions |
| AXA Investment Managers S.A. | $29 339 221 | 401 083 | 0,88% | Actions |
| Walleye Capital LLC | $29 032 972 | 1 399 854 | 0,87% | Actions |
| BANK OF AMERICA CORP /DE/ | $28 029 302 | 1 351 461 | 0,84% | Actions |
| Qube Research & Technologies Ltd | $26 585 445 | 1 281 844 | 0,80% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $24 611 432 | 1 186 665 | 0,74% | Actions |
| NORTHERN TRUST CORP | $24 398 059 | 1 176 377 | 0,73% | Actions |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $24 081 214 | 1 161 100 | 0,72% | Actions |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $21 706 360 | 1 046 594 | 0,65% | Actions |
| CITIGROUP INC | $21 132 360 | 1 018 918 | 0,63% | Actions |
| TUDOR INVESTMENT CORP ET AL | $21 106 040 | 1 017 649 | 0,63% | Actions |
| Swedbank AB | $20 958 994 | 1 010 559 | 0,63% | Actions |
| UBS Group AG | $18 868 401 | 909 759 | 0,56% | Actions |
| JANE STREET GROUP, LLC | $18 450 221 | 889 596 | 0,55% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $17 517 170 | 844 608 | 0,52% | Actions |
| JPMORGAN CHASE & CO | $16 959 200 | 817 890 | 0,51% | Actions |
| Bank of New York Mellon Corp | $16 627 817 | 801 727 | 0,50% | Actions |
| ALGERT GLOBAL LLC | $16 161 002 | 779 219 | 0,48% | Actions |
| BANK OF NOVA SCOTIA | $15 850 607 | 764 253 | 0,47% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $14 559 480 | 702 000 | 0,44% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $13 859 558 | 668 303 | 0,41% | Actions |
| Fundsmith LLP | $13 549 940 | 653 324 | 0,41% | Actions |
| BAILLIE GIFFORD & CO | $13 349 820 | 643 675 | 0,40% | Actions |
| Glenmede Investment Management, LP | $13 095 165 | 179 018 | 0,39% | Actions |
Initiés de la société 15 initiés · 8 dirigeants · 6 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jeffrey Tangney | Chief Executive Officer | 15 août 2026 F | 2 531 955 | 0 | 0 | $0 |
| Matthew Sonefeldt | Chief Financial Officer | 15 août 2026 F | 486 238 | 0 | 0 | $0 |
| Anna Bryson | Chief Financial Officer | 15 février 2026 F | 505 549 | 0 | 0 | $0 |
| Steven L Zatz | President | 24 septembre 2026 A | 204 291 | 0 | 0 | $0 |
| Siddharth Sitaram | Chief Accounting Officer | 15 septembre 2026 C | 96 045 | 0 | 8 | $-419 352 |
| Craig Overpeck | Senior Vice President, Commercial Operations | 16 mai 2024 S | 108 609 | 0 | 0 | $0 |
| Paul W. Jorgensen | Chief Revenue Officer | 15 février 2023 F | 313 059 | 0 | 0 | $0 |
| Joseph B. Kleine | Chief Commercial Officer | 12 janvier 2022 C | 441 760 | 0 | 0 | $0 |
| Watkin Phoebe L. Yang | Administrateur | 30 septembre 2026 S | 24 744 | 0 | 1 | $-34 456 |
| Kira Scherer Wampler | Administrateur | 1 septembre 2026 C | 27 923 | 0 | 9 | $-927 380 |
| Regina M. Benjamin | Administrateur | 27 août 2026 A | 58 987 | 0 | 1 | $-354 200 |
| Kevin Spain | Administrateur | 27 août 2026 A | 11 305 | 0 | 0 | $0 |
| Timothy S Cabral | Administrateur | 27 août 2026 A | 11 305 | 0 | 2 | $-793 325 |
| Andreas Stavropoulos | Détenteur de 10% | 28 juin 2021 C | · | 0 | 0 | $0 |
| Gilbert H Kliman | · | 2 août 2022 D | 449 960 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 80 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| GRPM · Invesco Exchange-Traded Fund Trust | 2,03% | 352 435 SH | 1 octobre 2026 | Quotidien |
| LSEQ · Harbor ETF Trust | 2,02% | 14 749 NS | 31 juillet 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,37% | 686 526 NS | 31 juillet 2026 | N-PORT |
| SMLL · Harbor ETF Trust | 1,35% | 9 053 NS | 31 juillet 2026 | N-PORT |
| RNIN · EA Series Trust | 1,13% | 98 433 NS | 31 juillet 2026 | N-PORT |
| MCOW · Pacer Funds Trust | 1,03% | 525 NS | 31 juillet 2026 | N-PORT |
| XMHQ · Invesco Exchange-Traded Fund Trust | 0,73% | 1 377 723 SH | 1 octobre 2026 | Quotidien |
| BUL · Pacer Funds Trust | 0,49% | 30 738 NS | 31 juillet 2026 | N-PORT |
| IHF · iShares Trust | 0,48% | 257 076 SH | 11 septembre 2026 | Quotidien |
| RFG · Invesco Exchange-Traded Fund Trust | 0,43% | 49 865 SH | 1 octobre 2026 | Quotidien |
| COWG · Pacer Funds Trust | 0,33% | 349 670 NS | 31 juillet 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,32% | 557 810 NS | 31 juillet 2026 | N-PORT |
| ESUM · Strategy Shares | 0,18% | 15 942 NS | 31 juillet 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,15% | 132 035 SH | 19 août 2026 | Quotidien |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,14% | 19 674 SH | 1 octobre 2026 | Quotidien |
| BKSE · BNY Mellon ETF Trust | 0,12% | 5 010 NS | 31 juillet 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 25 655 NS | 31 juillet 2026 | N-PORT |
| EWUS · iShares Trust | 0,11% | 52 582 SH | 11 septembre 2026 | Quotidien |
| VFQY · VANGUARD WELLINGTON FUND | 0,11% | 25 965 SH | 19 août 2026 | Quotidien |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,11% | 30 537 SH | 1 octobre 2026 | Quotidien |
| ESSC · Strategy Shares | 0,10% | 1 770 NS | 31 juillet 2026 | N-PORT |
| ISCG · iShares Trust | 0,10% | 39 666 SH | 11 septembre 2026 | Quotidien |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,10% | 33 755 NS | 31 juillet 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,08% | 97 882 NS | 31 juillet 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 76 205 SH | 1 octobre 2026 | Quotidien |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,08% | 215 901 SH | 19 août 2026 | Quotidien |
| PTMC · Pacer Funds Trust | 0,08% | 14 760 NS | 31 juillet 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,07% | 1 747 294 SH | 19 août 2026 | Quotidien |
| MIDU · Direxion Shares ETF Trust | 0,06% | 1 965 NS | 31 juillet 2026 | N-PORT |
| IYH · iShares Trust | 0,05% | 77 403 SH | 11 septembre 2026 | Quotidien |
| ESML · iShares Trust | 0,05% | 56 863 SH | 11 septembre 2026 | Quotidien |
| VFVA · VANGUARD WELLINGTON FUND | 0,05% | 21 465 SH | 19 août 2026 | Quotidien |
| SMMD · iShares Trust | 0,04% | 69 284 SH | 11 septembre 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,04% | 362 894 SH | 19 août 2026 | Quotidien |
| SMDX · Tidal Trust III | 0,04% | 2 374 NS | 31 juillet 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 57 235 NS | 31 juillet 2026 | N-PORT |
| WSML · iShares Trust | 0,03% | 53 898 SH | 11 septembre 2026 | Quotidien |
| IEUS · iShares Trust | 0,03% | 67 403 SH | 11 septembre 2026 | Quotidien |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,03% | 14 182 SH | 1 octobre 2026 | Quotidien |
| IWS · iShares Trust | 0,03% | 193 300 SH | 11 septembre 2026 | Quotidien |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1 537 722 SH | 19 août 2026 | Quotidien |
| VB · VANGUARD INDEX FUNDS | 0,03% | 3 033 009 SH | 19 août 2026 | Quotidien |
| IWR · iShares Trust | 0,02% | 538 960 SH | 11 septembre 2026 | Quotidien |
| RILA · Spinnaker ETF Series | 0,02% | 446 NS | 31 juillet 2026 | N-PORT |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,02% | 68 821 SH | 1 octobre 2026 | Quotidien |
| LRND · New York Life Investments ETF Trust | 0,02% | 2 967 NS | 31 juillet 2026 | N-PORT |
| SCZ · iShares Trust | 0,01% | 2 047 043 SH | 11 septembre 2026 | Quotidien |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 2 102 305 SH | 19 août 2026 | Quotidien |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 78 419 SH | 19 août 2026 | Quotidien |
| DXUV · Dimensional ETF Trust | 0,01% | 2 526 NS | 31 juillet 2026 | N-PORT |
| IUSG · iShares Trust | 0,01% | 114 485 SH | 11 septembre 2026 | Quotidien |
| IWD · iShares Trust | 0,01% | 288 768 SH | 11 septembre 2026 | Quotidien |
| IYY · iShares Trust | 0,00% | 5 691 SH | 11 septembre 2026 | Quotidien |
| ITOT · iShares Trust | 0,00% | 179 485 SH | 11 septembre 2026 | Quotidien |
| IWB · iShares Trust | 0,00% | 90 563 SH | 11 septembre 2026 | Quotidien |
| IWV · iShares Trust | 0,00% | 36 814 SH | 11 septembre 2026 | Quotidien |
| DFAC · Dimensional ETF Trust | 0,00% | 99 952 NS | 31 juillet 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 3 539 NS | 31 juillet 2026 | N-PORT |
| IEUR · iShares Trust | 0,00% | 334 412 SH | 11 septembre 2026 | Quotidien |
| IDEV · iShares Trust | 0,00% | 905 897 SH | 11 septembre 2026 | Quotidien |
| DFUS · Dimensional ETF Trust | 0,00% | 23 098 NS | 31 juillet 2026 | N-PORT |
| IEFA · iShares Trust | 0,00% | 4 370 632 SH | 11 septembre 2026 | Quotidien |
| DCOR · Dimensional ETF Trust | 0,00% | 3 112 NS | 31 juillet 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10 812 NS | 31 juillet 2026 | N-PORT |
| IXUS · iShares Trust | 0,00% | 862 826 SH | 11 septembre 2026 | Quotidien |
| TILT · FlexShares Trust | 0,00% | 158 NS | 31 juillet 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4 200 411 SH | 19 août 2026 | Quotidien |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 7 970 190 SH | 19 août 2026 | Quotidien |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 1 396 695 SH | 19 août 2026 | Quotidien |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 598 294 SH | 19 août 2026 | Quotidien |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 5 431 499 SH | 19 août 2026 | Quotidien |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,00% | 22 610 SH | 19 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10 642 SH | 19 août 2026 | Quotidien |
| VSGX · VANGUARD WORLD FUND | 0,00% | 95 335 SH | 19 août 2026 | Quotidien |
| ESGV · VANGUARD WORLD FUND | 0,00% | 29 384 SH | 19 août 2026 | Quotidien |
| IJH · iShares Trust | · | 4 694 508 SH | 11 septembre 2026 | Quotidien |
| IJK · iShares Trust | · | 774 827 SH | 11 septembre 2026 | Quotidien |
| XJH · iShares Trust | · | 18 322 SH | 8 septembre 2026 | Quotidien |
| ISCB · iShares Trust | · | 5 605 SH | 11 septembre 2026 | Quotidien |
| SMLF · iShares Trust | · | 103 220 SH | 11 septembre 2026 | Quotidien |
DOCS Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
Objectif de cours à 12 mois
18 analystes · 2026-10-03Objectif moyen $29.67 +6,2%
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| DOCS | $4.27B | 23.8 | 13.1% | 30.4% | 19.2% | 89.1% |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
| WAY | $6.27B | 53.7 | 16.5% | 10.2% | 3.2% | · |
| HTFL | $2.49B | -9.2 | 39.9% | -66.3% | 39.3% | 76.8% |
| SDGR | · | -12.7 | 23.3% | -40.4% | -29.2% | 55.7% |
| CERT | $1.40B | -881.0 | 8.8% | -0.38% | -0.15% | · |
| GDRX | · | 30.1 | 0.57% | 3.8% | 4.8% | · |
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | · |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | · |
| PHR | · | 335.8 | 14.5% | 0.48% | 0.73% | · |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.